Which thyroid autoantibodies should be ordered to evaluate a goitre?

Thyroid Autoantibodies for Goitre Evaluation

For evaluating a goitre, order thyroid peroxidase antibodies (TPOAb) as the primary autoantibody test, with consideration for TSH receptor antibodies (TRAb) if hyperthyroidism is suspected and thyroglobulin antibodies (TgAb) as a secondary marker of thyroid autoimmunity.

Primary Antibody Testing

TPOAb (Anti-Thyroid Peroxidase Antibodies)

• TPOAb is the most useful antibody for investigating goitre and should be routinely measured in the diagnostic workup 1
• TPOAb positivity helps diagnose both Graves' disease and Hashimoto's thyroiditis, the two major autoimmune causes of goitre 1
• In endemic goitre areas, TPOAb positivity ranges from 21.73% in nodular goitre to 89.28% in patients with Hashimoto's features 2
• TPOAb is present on the apical surface of thyroid follicular cells and is involved in cell-mediated cytotoxicity, making it a sensitive marker for autoimmune thyroid disease 1

TRAb (TSH Receptor Antibodies)

• TRAb is the hallmark antibody for Graves' disease and should be measured when hyperthyroidism accompanies the goitre 3
• TRAb helps distinguish between destructive thyroiditis and hyperthyroidism due to Graves' disease or nodular goiter when TSH is suppressed 4
• The TSH receptor antibodies can be stimulating (causing hyperthyroidism) or blocking (causing hypothyroidism), with different functional implications 1
• TRAb is specifically recommended for maternal and neonatal hyperthyroidism evaluation 1

Secondary Antibody Testing

TgAb (Anti-Thyroglobulin Antibodies)

• TgAb serves as an additional marker of thyroid autoimmunity, though less specific than TPOAb for goitre evaluation 3
• In toxic diffuse goitre, TgAb positivity is found in 57.9% of cases, compared to 27.6% in nodular goitre 5
• TgAb is primarily useful for monitoring thyroid carcinoma treatment rather than initial goitre diagnosis 1
• The combination of TPOAb and TgAb positivity defines the presence of thyroid autoimmunity 3

Clinical Algorithm for Antibody Selection

For diffuse goitre with normal TSH:

• Order TPOAb first to identify Hashimoto's thyroiditis 1, 6
• Consider TgAb as a complementary test if TPOAb is negative but clinical suspicion remains high 3

For diffuse goitre with suppressed TSH (<0.45 mIU/L):

• Order TRAb to confirm Graves' disease 4, 3
• TPOAb can be added as it is positive in many Graves' disease cases 1

For nodular goitre:

• TPOAb remains useful as 51.7% of nodular goitres show positivity, indicating underlying autoimmunity 2
• Autoantibody testing is less critical than ultrasound and fine needle aspiration for nodular disease 6

Important Clinical Considerations

Gender and Age Patterns

• Female patients show higher rates of antibody positivity (59% vs 51.67% in males) across all thyroid disorders 2
• The highest number of positive cases occurs in the 30-35 age group, though no definite age pattern exists 2

Predictive Value

• Baseline TPOAb positivity (OR=7.128) and TRAb positivity (OR=6.927) are significant risk factors for developing thyroid dysfunction 7
• Positive autoantibodies predict higher risk of progression to hypothyroidism in subclinical thyroid disease 1

Testing Pitfalls to Avoid

• Do not rely solely on antibody testing without measuring TSH and free T4 levels, as functional status guides management 4, 6
• Approximately 10% of normal controls may have positive antibodies without thyroid disease, so interpret results in clinical context 2
• Multiple B-cell-reactive epitopes exist for TPO, potentially causing variability between different assay methods 1